DISCUVA LIMITED

Company number 06169490

Date	Type	Description	View / Download
30 Jun 2020	TM02	Termination of appointment of Melissa Claire Strange as a secretary on 30 June 2020	(1 page)
05 Jun 2020	AP01	Appointment of Dr Ventzislav Kirilov Stefanov as a director on 27 May 2020	(2 pages)
05 Jun 2020	AP01	Appointment of Robert William Duggan as a director on 27 May 2020	(2 pages)
05 Jun 2020	TM01	Termination of appointment of Robert William Duggan as a director on 5 June 2020	(1 page)
05 Jun 2020	TM01	Termination of appointment of Ventzislav Kirilov Stefanov as a director on 5 June 2020	(1 page)
05 Jun 2020	AP01	Appointment of Dr Ventzislav Kirilov Stefanov as a director on 5 June 2020	(2 pages)
05 Jun 2020	AP01	Appointment of Robert William Duggan as a director on 5 June 2020	(2 pages)
05 Jun 2020	TM01	Termination of appointment of Glyn Owain Edwards as a director on 5 June 2020	(1 page)
24 Apr 2020	CS01	Confirmation statement made on 19 March 2020 with no updates	(3 pages)
20 Dec 2019	AA01	Current accounting period shortened from 31 January 2020 to 31 December 2019	(1 page)
27 Jun 2019	AA	Full accounts made up to 31 January 2019	(22 pages)
21 Mar 2019	CS01	Confirmation statement made on 19 March 2019 with updates	(5 pages)
15 Feb 2019	SH02	Sub-division of shares on 30 January 2019	(4 pages)
15 Feb 2019	SH01	Statement of capital following an allotment of shares on 30 January 2019 GBP 832,244.257	(4 pages)
15 Feb 2019	SH08	Change of share class name or designation	(2 pages)
15 Feb 2019	SH10	Particulars of variation of rights attached to shares	(3 pages)
14 Feb 2019	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES12 ‐ Resolution of varying share rights or name RES10 ‐ Resolution of allotment of securities	(2 pages)
01 Aug 2018	AA	Full accounts made up to 31 January 2018	(24 pages)
04 May 2018	CS01	Confirmation statement made on 19 March 2018 with updates	(6 pages)
20 Feb 2018	RESOLUTIONS	Resolutions RES01 ‐ Resolution of adoption of Articles of Association	(26 pages)
22 Jan 2018	PSC02	Notification of Summit Therapeutics Plc as a person with significant control on 23 December 2017	(2 pages)
22 Jan 2018	PSC07	Cessation of New Wave Ventures Llp as a person with significant control on 23 December 2017	(1 page)
18 Jan 2018	SH01	Statement of capital following an allotment of shares on 22 December 2017 GBP 54,668.624	(5 pages)
18 Jan 2018	SH01	Statement of capital following an allotment of shares on 23 December 2017 GBP 55,531.137	(8 pages)
09 Jan 2018	TM01	Termination of appointment of David Hugh Williams as a director on 23 December 2017	(1 page)